Cubist Systematic Strategies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$23M Buy
901,100
+10,300
+1% +$254K 0.11% 235
2025
Q2
$21.6M Buy
890,800
+842,900
+1,760% +$19.7M 0.1% 269
2025
Q1
$1.21M Sell
47,900
-121,100
-72% -$3.17M 0.01% 1712
2024
Q4
$4.48M Buy
169,000
+86,400
+105% +$2.34M 0.03% 902
2024
Q3
$2.39M Buy
82,600
+55,700
+207% +$1.62M 0.01% 1325
2024
Q2
$753K Sell
26,900
-217,400
-89% -$5.99M 0.01% 1914
2024
Q1
$6.78M Sell
244,300
-74,400
-23% -$2.06M 0.04% 764
2023
Q4
$9.18M Buy
318,700
+232,400
+269% +$7.03M 0.06% 501
2023
Q3
$2.86M Sell
86,300
-48,800
-36% -$1.73M 0.02% 1115
2023
Q2
$4.96M Sell
135,100
-87,400
-39% -$3.4M 0.03% 856
2023
Q1
$9.08M Sell
222,500
-130,600
-37% -$5.64M 0.06% 518
2022
Q4
$18.1M Buy
353,100
+189,500
+116% +$9.09M 0.11% 185
2022
Q3
$7.16M Buy
163,600
+20,600
+14% +$1M 0.04% 743
2022
Q2
$7.5M Buy
+143,000
New +$7.29M 0.05% 651

Other funds holding PFE

Cubist Systematic Strategies's PFE Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Pfizer (PFE) in Q1 2025, closing a stake of 32,976 shares — an estimated $863K sold.

Cubist Systematic Strategies first reported a position in PFE in Q2 2014 and held it in 41 quarters. The position peaked at $24M in Q1 2020. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 32,976 Pfizer shares in Q1 2025, an estimated $863K.
  • Cubist Systematic Strategies first reported a position in Pfizer in Q2 2014 and held it in 41 quarters.
  • Cubist Systematic Strategies's Pfizer position peaked at $24M in Q1 2020.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.